Investigational Studies

LONDON, Nov. 22, 2016 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (GWPH) (GWP.L) (“GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, today announced that Justin Gover, GW’s Chief Executive Officer, will present at the 28th Annual Piper Jaffray Healthcare Conference on Tuesday, 29 […]

by

Along with electing Donald J. Trump as the United States’ 45th president in the Nov. 8 election, the legal cannabis industry scored landmark victories in concurrent ballot measures in several states, raising hope for those who support developing new cannabis-based therapies for unmet medical needs, especially in the management of chronic pain. Use of recreational […]

by

November 9, 2016 (Investorideas.com Newswire) Investorideas.com, a global news source and investor resource issues an updated directory and news alert for Marijuana and Hemp Stocks following the US election and the legalization in new States. Approved: California voters approved recreational marijuana Approved: Massachusetts also voted for recreational marijuana Approved: Nevada approved recreational marijuana Approved: Florida […]

by

November 9, 2016 (Investorideas.com Newswire) Investorideas.com, a global news source and investor resource issues an updated directory and news alert for Marijuana and Hemp Stocks following the US election and the legalization in new States. Approved: California voters approved recreational marijuana Approved: Massachusetts also voted for recreational marijuana Approved: Nevada approved recreational marijuana Approved: Florida […]

by

CORAL SPRINGS, FL, Oct. 25, 2016 (Canada NewsWire via COMTEX) — The global marijuana and cannabis industries remain very active of late heading into the elections, as research and product development of new uses for varying strains and extracts of CBD, hemp cannabis propel the industry forward. Marijuana leaders active in the markets this week […]

by

Marijuana legalization will unleash misery on Arizona, according to a wave of television ads that started rolling out across the state last month. Replete with ominous music, the advertisements feature lawmakers and teachers who paint a bleak future for Arizona’s children if voters approve Proposition 205, a measure that would allow people aged 21 and […]

by

Ohio is now one of 26 states to legalize medical marijuana, and a committee appointed by the governor will begin drafting implementation rules this month. Members say one priority is to ensure the state protects the community and the patients who will ultimately use the marijuana products. “We don’t want this to turn into another […]

by

OTTAWA, ONTARIO–(Marketwired – Sept. 6, 2016) – PhytoPain Pharma Inc. (“PhytoPain Pharma” or “PPP“), a subsidiary of GrowPros Cannabis Ventures Inc. (“GrowPros” or the “Company“) (CSE:GCI), today announces the submission to the US Food and Drug Administration (FDA) Office of Orphan Products Development, two applications for Orphan Drug Designation for delta-9-tetrahydrocannibinol and cannabidiol for the […]

by

GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) has been running up the charts in recent months easily surpassing $100 a share and taking charge as the biggest pot stock on the markets. The stock recently got a boost after the Company announced Primary endpoint achieved in both Epidiolex doses with high statistical significance compared to placebo. GWPH […]

by

Epidiolex is an orphan drug that is pharmaceutical cannabidiol, not medical marijuana. The drug helps treat various types of pediatric epilepsy, including Dravet syndrome and Lennox-Gastaut syndrome. GW Pharma’s study revealed that patients taking 20 mg of Epidiolex had a medium reduction in monthly seizures of 42 percent versus a 17 percent reduction for those […]

by

Editorial: Peter Wehrwein, Editor Advertising: Maureen Dwyer Liberti,     Vice President, Group Publisher Production: Dawn Flook,     Director of Production Services Circulation: Jackie Ott,     Circulation Manager Webmaster: Webmaster … read more at: http://www.managedcaremag.com/news/company-prepares-submit-cannabis-based-epilepsy-treatment-fda

by